2009
DOI: 10.1016/j.biomaterials.2009.07.051
|View full text |Cite
|
Sign up to set email alerts
|

Biodegradable micelles with sheddable poly(ethylene glycol) shells for triggered intracellular release of doxorubicin

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

11
364
1
1

Year Published

2012
2012
2021
2021

Publication Types

Select...
6
4

Relationship

0
10

Authors

Journals

citations
Cited by 422 publications
(377 citation statements)
references
References 43 publications
11
364
1
1
Order By: Relevance
“…44 The total amount of non-aggregated PEG-PCL-4 molecules in the final preparation was 0.45 mg, based on the volume of aqueous phase in the final preparation of 25 ml and the above value of CMC. The concentration of PEG-PCL-4 in the organic phase was 1.0 mg ml -1 and thus, the total amount of PEG-PCL-4 incorporated in the micelles was 4.55 mg.…”
Section: Copolymer Molecular Weight Mw the Results Inmentioning
confidence: 99%
“…44 The total amount of non-aggregated PEG-PCL-4 molecules in the final preparation was 0.45 mg, based on the volume of aqueous phase in the final preparation of 25 ml and the above value of CMC. The concentration of PEG-PCL-4 in the organic phase was 1.0 mg ml -1 and thus, the total amount of PEG-PCL-4 incorporated in the micelles was 4.55 mg.…”
Section: Copolymer Molecular Weight Mw the Results Inmentioning
confidence: 99%
“…The critical micelle concentration (CMC) was determined by fluorescence measurement using pyrene as the fluorescent probe at 25°C. 24,25 The concentration of block copolymer was varied from 1 × 10 −6 to 0.1 mg/mL. Briefly, aliquots of pyrene solution (10 µM) were added into containers and dried with nitrogen.…”
Section: Characterizationmentioning
confidence: 99%
“…Similar fast release found at the initial 4 hours might be ascribed to the drug located in the hydrophilic shell or adhered to the surface of the NPs. 54 Then the remaining DOX, probably loaded deep in the hydrophobic cores, presented a different release profile in different DTT concentrations. In the presence of 10 μM DTT, the less-efficient release during the following 44 hours suggested that the insoluble DOX was difficult to be released from the inner core as reported before, 55 which met the demand that the integrity of vehicle was maintained well and the loss of drug minimized before reaching the target cells.…”
mentioning
confidence: 99%